Blood PressureNCT06565702
Clinical Trial on the Accuracy of Blood Pressure Measurement by YE990 Medical Automatic Electronic Sphygmomanometer
An observational study of Blood Pressure, run by The First Affiliated Hospital of Anhui Medical University at 1 site in China.
Trial summary
This study was a single-center, open-ended, self-controlled clinical study . Same armsequential method was used to measure the blood pressure of the subjects,inclusion of ≥85 subjects aged 12 years or older who met the enrollment criteria.In accordance with the "Association for the Advancement of Medical… Read more about this study
- Who is it for?
- Ages 12 years and older
- Conditions the study is for
- Blood Pressure
- How many people
- 85 participants
- Where
- 1 siteChina
- Study dates
- 20 Aug 2024to 30 Dec 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 years and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Healthy people over 12 years of age who meet the criteria for admission to the platoon
Who may be able to join
- Subjects should meet all of the following requirements for inclusion in the study:
- Both sexes; at least 30% of the subjects are male and at least 30% of the subjects are female.
- Subject's age > 12 years.
- Arm circumference distribution:
- At least 20% of the subjects should have arm circumference within each quarter interval of the total arm circumference range;
- At least 10% of the subjects should have arm circumference within the upper one-eighth interval of the total arm circumference range;
Show all 16Show fewer
- At least 10% of the subjects shall have an arm circumference within the lower one-eighth interval of the total arm circumference range.
- Blood pressure distribution:
- At least 5% of subjects shall have a systolic blood pressure ≤100 mmHg (13.33 kPa);
- At least 5% of subjects shall have a systolic blood pressure ≥ 160 mmHg (21.33 kPa);
- At least 20% of subjects should have a systolic blood pressure ≥ 140 mmHg (18.66 kPa);
- Diastolic blood pressure should be ≤60 mmHg (8.0 kPa) in at least 5% of subjects;
- Diastolic blood pressure should be ≥100 mmHg (13.33 kPa) in at least 5% of subjects; (f) At least 20% of subjects should have a diastolic blood pressure ≥85 mmHg (11.33 kPa);
- Subjects must be willing and able to comply with the study procedures by signing an informed consent form after being informed about the study.
- consent form after understanding the contents of the study.
- Good compliance and ability to complete the clinical trial.
Who cannot join
- Subjects who fulfill any of the following requirements cannot be included in the study:
- Mental illness, impaired consciousness, or other conditions that prevent them from cooperating with the study; (2) Require hemodialysis; (3) Taking anticoagulant drugs for cardiovascular diseases; (4) Pregnant and lactating women; (5) Patients with cardiac arrhythmia; (6) Patients with peripheral arterial disease and diseases that may affect arterial compliance; (7) Other conditions that are considered by the physician to be unsuitable for enrollment.
- -
Trial locations and contacts
1 site in 1 country.
Ji Nian Wang contact
China1 site
The First Affiliated Hospital of Anhui Medical University Hospital
Hefei, Anhui, 230000
Hejun Liu
About this study
This study was a single-center, open-ended, self-controlled clinical study . Same armsequential method was used to measure the blood pressure of the subjects,inclusion of ≥85 subjects aged 12 years or older who met the enrollment criteria.In accordance with the "Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Universal Standard (ISO 81060-2:2018/Amd 1:2020)",the purpose of this study was to compare the blood pressure and pulse rate measured by an electronic sphygmomanometer with those measured by a reference sphygmomanometer (an upper-arm noninvasive auscultatory sphygmomanometer) and by palpation of the radial artery, and then to evaluate the accuracy and safety of the measurement of systolic blood pressure, diastolic blood pressure, and pulse rate by a fully automated electronic sphygmomanometer for medical use (Model No. YE990), which is manufactured by Jiangsu Yuyue Medical Equipment Co.
Read the detailed description
This study was a single-center, open-ended, self-controlled clinical study . Same armsequential method was used to measure the blood pressure of the subjects,inclusion of ≥85 subjects aged 12 years or older who met the enrollment criteria.In accordance with the "AAMI/ESH/ISO Universal Standard (ISO 81060-2:2018/Amd 1:2020)",the purpose of this study was to compare the blood pressure and pulse rate measured by an electronic sphygmomanometer with those measured by a reference sphygmomanometer (an upper-arm noninvasive auscultatory sphygmomanometer) and by palpation of the radial artery, and then to evaluate the accuracy and safety of the measurement of systolic blood pressure, diastolic blood pressure, and pulse rate by a fully automated electronic sphygmomanometer for medical use (Model No. YE990), which is manufactured by Jiangsu Yuyue Medical Equipment Co.
(One) criteria for admission Inclusion Criteria
Subjects should meet all of the following requirements for inclusion in the study:
- Both sexes; at least 30% of the subjects are male and at least 30% of the subjects are female.
- Subject's age > 12 years.
- Arm circumference distribution:
- At least 20% of the subjects should have arm circumference within each quarter interval of the total arm circumference range;
- At least 10% of the subjects should have arm circumference within the upper one-eighth interval of the total arm circumference range;
- At least 10% of the subjects shall have an arm circumference within the lower one-eighth interval of the total arm circumference range.
- Blood pressure distribution:
- At least 5% of subjects shall have a systolic blood pressure ≤100 mmHg (13.33 kPa);
- At least 5% of subjects shall have a systolic blood pressure ≥ 160 mmHg (21.33 kPa);
- At least 20% of subjects should have a systolic blood pressure ≥ 140 mmHg (18.66 kPa);
- Diastolic blood pressure should be ≤60 mmHg (8.0 kPa) in at least 5% of subjects;
- Diastolic blood pressure should be ≥100 mmHg (13.33 kPa) in at least 5% of subjects; (f) At least 20% of subjects should have a diastolic blood pressure ≥85 mmHg (11.33 kPa);
- Subjects must be willing and able to comply with the study procedures by signing an informed consent form after being informed about the study. consent form after understanding the contents of the study. (6) Good compliance and ability to complete the clinical trial. 2. Exclusion Criteria
Subjects who fulfill any of the following requirements cannot be included in the study:
- Mental illness, impaired consciousness, or other conditions that prevent them from cooperating with the study;
- Require hemodialysis;
- Taking anticoagulant drugs for cardiovascular diseases;
- Pregnant and lactating women;
- Patients with cardiac arrhythmia;
- Patients with peripheral arterial disease and diseases that may affect arterial compliance;
- Other conditions that are considered by the physician to be unsuitable for enrollment.
(Two)Evaluation methods 2.1. Evaluation of effectiveness According to the standard requirements of "AAMI/ESH/ISO Universal Standard (ISO 81060-2:2018/Amd 1:2020)", the relationship between the mean value of the error and the standard deviation, the consistency between the measured and reference blood pressure values, and the relationship between the arm circumference and the measurement error should be evaluated.
- Error mean and standard deviation Calculate the mean and standard deviation of the difference (i.e. error) between the measured and reference blood pressure values, and the result shall meet the requirements of ISO 81060-2:2018/Amd 1:2020 5.4.1.2.
- Agreement between measured and reference blood pressure values (Bland-Altman analysis) For each measurement position, a scatter plot of the difference between the investigator and the device under test is obtained for each comparison of the investigator and the device under test, and the values of systolic and diastolic blood pressures shall be plotted separately.
- Relationship between arm circumference and measurement error (Bland-Altman analysis) The relationship between upper arm circumference and measurement error is shown by plotting a scatter plot.
- Relative pulse rate error Descriptive statistics of relative error in pulse rate.
2.2. Safety evaluation According to the "Code for Quality Management of Clinical Trials of Medical Devices" (2022) iii, medical devices should be collected and recorded when conducting clinical trials.
When conducting clinical trials of medical devices, the occurrence of adverse events and defects of the devices in the course of use by the subjects should be collected and recorded.
- Incidence of adverse events;
- Incidence of device defects.
2.3. Evaluation of product performance Clinical use performance evaluation is mainly for product stability evaluation, the specific evaluation criteria are as follows, the following items if evaluation
If the evaluation of the following items is "yes", it is necessary to specifically describe the cause of the failure:
Evaluation item 1: electronic sphygmomanometer power on and off Yes: Cannot be turned on and/or off normally; No: can be turned on and off normally. Evaluation Item II: Whether the device automatically shuts off during the checking process Yes: Automatic shutdown during the inspection; No: There is no automatic shutdown during the inspection. Evaluation item 3: Whether there is any abnormal interruption due to the machine during the inspection process.
Yes: Abnormal interruptions occurred during the inspection process due to the machine; No: No abnormal interruptions occurred during the inspection. Evaluation item 4: Whether inflation and exhaust failures occurred during the inspection process Yes: Inflation and/or exhaust failure occurred during the inspection; No: No inflation and exhaust failure occurred during the inspection. Evaluation item 5: Whether air leakage occurred during the inspection process Yes: Air leakage occurred; No: no air leakage occurred.
(Three)Test medical device and control medical device
- Test medical equipment (blood pressure monitor) Name of device: Medical automatic electronic sphygmomanometer (Model: YE990) Registrant name: Jiangsu Yuyue Medical Equipment Co. Registration Certificate No.: Su Meizhi Quasi 20222071271
- Control medical devices (reference sphygmomanometer) Name of device: Sphygmomanometer - stethoscope health care box (Model: A type) Registrant name: Jiangsu Yuyue Medical Equipment Co. Certificate of Registration No.: SuMeChiQi 20152070947
(Four)statistical analysis
- General principles Descriptive statistical analysis: qualitative indicators are described by frequency tables and percentages; quantitative indicators are described by mean, standard deviation, minimum, median, maximum, upper quartile (Q1) and lower quartile (Q3).
- Content of statistical analysis
- The number of subjects enrolled, dislodged, and completed cases, and a list of reasons why subjects withdrew from the study.
- Demographic and vital sign data of the subjects Quantitative data were analyzed by describing their number of cases, mean, standard deviation, minimum, median, maximum, and upper quartile. maximum, upper quartile (Q1), and lower quartile (Q3); qualitative data were analyzed by describing the number of cases and their proportion of the total number of subjects. The qualitative data were analyzed by describing the number of cases and their percentages.
- Validity analysis Error mean and standard deviation According to ISO 81060-2:2018/Amd 1:2020 5.4.1.2, the error mean and standard deviation deviation should meet the following evaluation criteria: Criterion 1: Calculate the mean and standard deviation of the errors of the 255 groups of measured and reference blood pressure values for 85 subjects.
Criterion 1: Calculate the mean and standard deviation of the errors of 255 sets of measured and reference blood pressure values of 85 subjects, and compare the systolic and diastolic blood pressures separately, with the mean value of the error not exceeding ±5 mmHg and the standard deviation not exceeding 8 mmHg.
Criterion 2: Comparison of the mean of the three sets of errors for each subject, comparing systolic and diastolic blood pressures separately.
Agreement between measured and reference blood pressure values (Bland-Altman analysis) According to ISO 81060-2:2018/Amd 1:2020, a scatter plot of the difference between the reference device and the device under test should be plotted for each occasion, and the difference between systolic and diastolic blood pressure should be plotted separately. x-axis indicates the mean value of the 2 methods of measurement for each subject, and y-axis indicates the difference between the 2 methods of measurement for each subject.
Relationship between arm circumference and measurement error (Bland-Altman analysis) Plot the results of all subjects by arm circumference according to ISO 81060-2:2018/Amd 1:2020 5.1.4 d. The x-axis shows the actual arm circumference of the subject and the y-axis shows the difference between the measured blood pressure value and the reference blood pressure value.
Pulse Rate Error The relative error of the pulse rate measurement is counted.
- Conditions
- Blood Pressure
- Keywords
- accuracy, systolic blood pressure, diastolic blood pressure, pulse rate, 12 years of age or older, automatic electronic sphygmomanometers
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Test medical equipment (blood pressure monitor) | Name of device: Medical automatic electronic sphygmomanometer (Model: YE990) Registrant name: Jiangsu Yuyue Medical Equipment Co. Registration Certificate No.: Su Meizhi Quasi 20222071271 The minimum number of valid cases for the evaluation of the electronic sphygmomanometer with auscultation as a control, with sequential measurements in the same arm, was 85, of which 3 valid data sets were provided by each subject, for a total of 255 data sets. | |
| Control medical devices (reference sphygmomanometer) | Name of device: Sphygmomanometer - stethoscope health care box (Model: A type) Registrant name: Jiangsu Yuyue Medical Equipment Co. Certificate of Registration No.: SuMeChiQi 20152070947 The minimum number of valid cases for the evaluation of the electronic sphygmomanometer with auscultation as a control, with sequential measurements in the same arm, was 85, of which 3 valid data sets were provided by each subject, for a total of 255 data sets. |
What is being measured
The primary outcome is the main question the study is designed to answer.
To evaluate the accuracy of the arm-type electronic blood pressure monitor (Model: YE660D) in measuring systolic blood pressure, diastolic blood pressure and pulse rate in adults aged 12 years and above.
Evaluate the relationship between the mean and standard deviation of error, the agreement between the measured and reference blood pressure values, and the relationship between arm circumference and measurement error.Reference standard: 255 sets of data from 85 subjects were calculated and compared separately for systolic and diastolic blood pressure, with a mean deviation of not more than ±5 mmHg and a standard deviation of not more than 8 mmHg.
Measured: August 20, 2024 - December 30, 2025
Secondary outcomes (1)
Collect and document the occurrence of adverse events and device defects in subjects during use
- Incidence of adverse events;
- Incidence of device defects.
Measured: August 20, 2024 - December 30, 2025
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Aug 2024
- Study start20 Aug 2024 (estimated)
- Primary completion20 Aug 2025 (estimated)
- Study completion30 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Blood PressureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case crossover
- Time perspective
- Prospective
- Enrolment
- 85 participants (estimated)
Sponsor and investigators
- Lead sponsor
- The First Affiliated Hospital of Anhui Medical University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hejun Liu, The First Affiliated Hospital of Anhui Medical University
- Investigators
- Hejun Liu, Principal investigator, The First Affiliated Hospital of Anhui Medical University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06565702
- Sponsor's protocol ID
- YC20240201
- Status last verified
- Aug 2024
- First submitted
- 15 Jul 2024
- Last updated
- 22 Aug 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Xu D, Tang H, Wang C, Cheng H, Wu W, Lu Q, Liu H. Validation of the YuWell YE990 medical automatic electronic blood pressure monitor according to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization Universal Standard (ISO 81060-2:2018/Amd.1:2020). Blood Press Monit. 2025 Aug 1;30(4):191-195. doi: 10.1097/MBP.0000000000000755. Epub 2025 May 6.
PubMed 40327332
Study at a glance
From the registry record, last updated by the sponsor on 22 Aug 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical Trial on the Accuracy of Blood Pressure Measurement by YE990 Medical Automatic Electronic Sphygmomanometer
- ClinicalTrials.gov ID
- NCT06565702
- Acronym / sponsor ID
- YC20240201
- Conditions
- Blood Pressure
- Keywords
- accuracy, systolic blood pressure, diastolic blood pressure, pulse rate, 12 years of age or older, automatic electronic sphygmomanometers
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 85 participants (estimated)
- Lead sponsor
- The First Affiliated Hospital of Anhui Medical UniversityUniversity, hospital or other
- Study start
- 20 Aug 2024 (estimated)
- Primary completion
- 20 Aug 2025 (estimated)
- Study completion
- 30 Dec 2025 (estimated)
- First posted
- 22 Aug 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study was a single-center, open-ended, self-controlled clinical study . Same armsequential method was used to measure the blood pressure of the subjects,inclusion of ≥85 subjects aged 12 years or older who met the enrollment criteria.In accordance with the "Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Universal Standard (ISO 81060-2:2018/Amd 1:2020)",the purpose of this study was to compare the blood pressure and pulse rate measured by an electronic sphygmomanometer with those measured by a reference sphygmomanometer (an upper-arm noninvasive auscultatory sphygmomanometer) and by palpation of the radial artery, and then to evaluate the accuracy and safety of the measurement of systolic blood pressure, diastolic blood pressure, and pulse rate by a fully automated electronic sphygmomanometer for medical use (Model No. YE990), which is manufactured by Jiangsu Yuyue Medical Equipment Co.
Detailed description
This study was a single-center, open-ended, self-controlled clinical study . Same armsequential method was used to measure the blood pressure of the subjects,inclusion of ≥85 subjects aged 12 years or older who met the enrollment criteria.In accordance with the "AAMI/ESH/ISO Universal Standard (ISO 81060-2:2018/Amd 1:2020)",the purpose of this study was to compare the blood pressure and pulse rate measured by an electronic sphygmomanometer with those measured by a reference sphygmomanometer (an upper-arm noninvasive auscultatory sphygmomanometer) and by palpation of the radial artery, and then to evaluate the accuracy and safety of the measurement of systolic blood pressure, diastolic blood pressure, and pulse rate by a fully automated electronic sphygmomanometer for medical use (Model No. YE990), which is manufactured by Jiangsu Yuyue Medical Equipment Co.
(One) criteria for admission Inclusion Criteria
Subjects should meet all of the following requirements for inclusion in the study:
- Both sexes; at least 30% of the subjects are male and at least 30% of the subjects are female.
- Subject's age > 12 years.
- Arm circumference distribution:
- At least 20% of the subjects should have arm circumference within each quarter interval of the total arm circumference range;
- At least 10% of the subjects should have arm circumference within the upper one-eighth interval of the total arm circumference range;
- At least 10% of the subjects shall have an arm circumference within the lower one-eighth interval of the total arm circumference range.
- Blood pressure distribution:
- At least 5% of subjects shall have a systolic blood pressure ≤100 mmHg (13.33 kPa);
- At least 5% of subjects shall have a systolic blood pressure ≥ 160 mmHg (21.33 kPa);
- At least 20% of subjects should have a systolic blood pressure ≥ 140 mmHg (18.66 kPa);
- Diastolic blood pressure should be ≤60 mmHg (8.0 kPa) in at least 5% of subjects;
- Diastolic blood pressure should be ≥100 mmHg (13.33 kPa) in at least 5% of subjects; (f) At least 20% of subjects should have a diastolic blood pressure ≥85 mmHg (11.33 kPa);
- Subjects must be willing and able to comply with the study procedures by signing an informed consent form after being informed about the study. consent form after understanding the contents of the study. (6) Good compliance and ability to complete the clinical trial. 2. Exclusion Criteria
Subjects who fulfill any of the following requirements cannot be included in the study:
- Mental illness, impaired consciousness, or other conditions that prevent them from cooperating with the study;
- Require hemodialysis;
- Taking anticoagulant drugs for cardiovascular diseases;
- Pregnant and lactating women;
- Patients with cardiac arrhythmia;
- Patients with peripheral arterial disease and diseases that may affect arterial compliance;
- Other conditions that are considered by the physician to be unsuitable for enrollment.
(Two)Evaluation methods 2.1. Evaluation of effectiveness According to the standard requirements of "AAMI/ESH/ISO Universal Standard (ISO 81060-2:2018/Amd 1:2020)", the relationship between the mean value of the error and the standard deviation, the consistency between the measured and reference blood pressure values, and the relationship between the arm circumference and the measurement error should be evaluated.
- Error mean and standard deviation Calculate the mean and standard deviation of the difference (i.e. error) between the measured and reference blood pressure values, and the result shall meet the requirements of ISO 81060-2:2018/Amd 1:2020 5.4.1.2.
- Agreement between measured and reference blood pressure values (Bland-Altman analysis) For each measurement position, a scatter plot of the difference between the investigator and the device under test is obtained for each comparison of the investigator and the device under test, and the values of systolic and diastolic blood pressures shall be plotted separately.
- Relationship between arm circumference and measurement error (Bland-Altman analysis) The relationship between upper arm circumference and measurement error is shown by plotting a scatter plot.
- Relative pulse rate error Descriptive statistics of relative error in pulse rate.
2.2. Safety evaluation According to the "Code for Quality Management of Clinical Trials of Medical Devices" (2022) iii, medical devices should be collected and recorded when conducting clinical trials.
When conducting clinical trials of medical devices, the occurrence of adverse events and defects of the devices in the course of use by the subjects should be collected and recorded.
- Incidence of adverse events;
- Incidence of device defects.
2.3. Evaluation of product performance Clinical use performance evaluation is mainly for product stability evaluation, the specific evaluation criteria are as follows, the following items if evaluation
If the evaluation of the following items is "yes", it is necessary to specifically describe the cause of the failure:
Evaluation item 1: electronic sphygmomanometer power on and off Yes: Cannot be turned on and/or off normally; No: can be turned on and off normally. Evaluation Item II: Whether the device automatically shuts off during the checking process Yes: Automatic shutdown during the inspection; No: There is no automatic shutdown during the inspection. Evaluation item 3: Whether there is any abnormal interruption due to the machine during the inspection process.
Yes: Abnormal interruptions occurred during the inspection process due to the machine; No: No abnormal interruptions occurred during the inspection. Evaluation item 4: Whether inflation and exhaust failures occurred during the inspection process Yes: Inflation and/or exhaust failure occurred during the inspection; No: No inflation and exhaust failure occurred during the inspection. Evaluation item 5: Whether air leakage occurred during the inspection process Yes: Air leakage occurred; No: no air leakage occurred.
(Three)Test medical device and control medical device
- Test medical equipment (blood pressure monitor) Name of device: Medical automatic electronic sphygmomanometer (Model: YE990) Registrant name: Jiangsu Yuyue Medical Equipment Co. Registration Certificate No.: Su Meizhi Quasi 20222071271
- Control medical devices (reference sphygmomanometer) Name of device: Sphygmomanometer - stethoscope health care box (Model: A type) Registrant name: Jiangsu Yuyue Medical Equipment Co. Certificate of Registration No.: SuMeChiQi 20152070947
(Four)statistical analysis
- General principles Descriptive statistical analysis: qualitative indicators are described by frequency tables and percentages; quantitative indicators are described by mean, standard deviation, minimum, median, maximum, upper quartile (Q1) and lower quartile (Q3).
- Content of statistical analysis
- The number of subjects enrolled, dislodged, and completed cases, and a list of reasons why subjects withdrew from the study.
- Demographic and vital sign data of the subjects Quantitative data were analyzed by describing their number of cases, mean, standard deviation, minimum, median, maximum, and upper quartile. maximum, upper quartile (Q1), and lower quartile (Q3); qualitative data were analyzed by describing the number of cases and their proportion of the total number of subjects. The qualitative data were analyzed by describing the number of cases and their percentages.
- Validity analysis Error mean and standard deviation According to ISO 81060-2:2018/Amd 1:2020 5.4.1.2, the error mean and standard deviation deviation should meet the following evaluation criteria: Criterion 1: Calculate the mean and standard deviation of the errors of the 255 groups of measured and reference blood pressure values for 85 subjects.
Criterion 1: Calculate the mean and standard deviation of the errors of 255 sets of measured and reference blood pressure values of 85 subjects, and compare the systolic and diastolic blood pressures separately, with the mean value of the error not exceeding ±5 mmHg and the standard deviation not exceeding 8 mmHg.
Criterion 2: Comparison of the mean of the three sets of errors for each subject, comparing systolic and diastolic blood pressures separately.
Agreement between measured and reference blood pressure values (Bland-Altman analysis) According to ISO 81060-2:2018/Amd 1:2020, a scatter plot of the difference between the reference device and the device under test should be plotted for each occasion, and the difference between systolic and diastolic blood pressure should be plotted separately. x-axis indicates the mean value of the 2 methods of measurement for each subject, and y-axis indicates the difference between the 2 methods of measurement for each subject.
Relationship between arm circumference and measurement error (Bland-Altman analysis) Plot the results of all subjects by arm circumference according to ISO 81060-2:2018/Amd 1:2020 5.1.4 d. The x-axis shows the actual arm circumference of the subject and the y-axis shows the difference between the measured blood pressure value and the reference blood pressure value.
Pulse Rate Error The relative error of the pulse rate measurement is counted.
Study design
- Observational model
- Case crossover
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Test medical equipment (blood pressure monitor) | – | –Name of device: Medical automatic electronic sphygmomanometer (Model: YE990) Registrant name: Jiangsu Yuyue Medical Equipment Co. Registration Certificate No.: Su Meizhi Quasi 20222071271 The minimum number of valid cases for the evaluation of the electronic sphygmomanometer with auscultation as a control, with sequential measurements in the same arm, was 85, of which 3 valid data sets were provided by each subject, for a total of 255 data sets. |
| Control medical devices (reference sphygmomanometer) | – | –Name of device: Sphygmomanometer - stethoscope health care box (Model: A type) Registrant name: Jiangsu Yuyue Medical Equipment Co. Certificate of Registration No.: SuMeChiQi 20152070947 The minimum number of valid cases for the evaluation of the electronic sphygmomanometer with auscultation as a control, with sequential measurements in the same arm, was 85, of which 3 valid data sets were provided by each subject, for a total of 255 data sets. |
Who may qualify
- Ages
- 12 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Healthy people over 12 years of age who meet the criteria for admission to the platoon
Key inclusion criteria (16 listed)
- Both sexes; at least 30% of the subjects are male and at least 30% of the subjects are female.
- Subject's age > 12 years.
- Arm circumference distribution:
- Blood pressure distribution:
- Subjects must be willing and able to comply with the study procedures by signing an informed consent form after being informed about the study.
Key exclusion criteria (3 listed)
- Mental illness, impaired consciousness, or other conditions that prevent them from cooperating with the study; (2) Require hemodialysis; (3) Taking anticoagulant drugs for cardiovascular diseases; (4) Pregnant and lactating women; (5) Patients with cardiac arrhythmia; (6) Patients with peripheral arterial disease and diseases that may affect arterial compliance; (7) Other conditions that are considered by the physician to be unsuitable for enrollment.
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
To evaluate the accuracy of the arm-type electronic blood pressure monitor (Model: YE660D) in measuring systolic blood pressure, diastolic blood pressure and pulse rate in adults aged 12 years and above.
Time frame: August 20, 2024 - December 30, 2025
Evaluate the relationship between the mean and standard deviation of error, the agreement between the measured and reference blood pressure values, and the relationship between arm circumference and measurement error.Reference standard: 255 sets of data from 85 subjects were calculated and compared separately for systolic and diastolic blood pressure, with a mean deviation of not more than ±5 mmHg and a standard deviation of not more than 8 mmHg.
1 secondary outcome
Collect and document the occurrence of adverse events and device defects in subjects during use
Time frame: August 20, 2024 - December 30, 2025
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Aug 2024.
- Derived from this study: PubMed 40327332Xu D, Tang H, Wang C, Cheng H, Wu W, Lu Q, Liu H. Validation of the YuWell YE990 medical automatic electronic blood pressure monitor according to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization Universal Standard (ISO 81060-2:2018/Amd.1:2020). Blood Press Monit. 2025 Aug 1;30(4):191-195. doi: 10.1097/MBP.0000000000000755. Epub 2025 May 6.
Related trials for Blood Pressure
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
RecruitingPhase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
Recruiting
Guiding Optimal Blood Pressure Management in Peritoneal Dialysis Pilot Trial
End Stage Kidney Disease (ESKD), Hypertension (HTN)
RecruitingPhase 4
Hematological Safety of Dipyrone Versus Paracetamol After Dental Extractions
Hematologic Test, Agranulocytosis
Not yet recruiting
Acute Effects of Mat Pilates on Blood Pressure Response to Mental Stress in Higher Education Teachers
Behavior
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ji Nian Wang contact
Hejun Liu principal investigator
The First Affiliated Hospital of Anhui Medical University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Blood Pressure, run by The First Affiliated Hospital of Anhui Medical University at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 16 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 22 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Hejun Liu (0511-86900833, hejun_liu123@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To evaluate the accuracy of the arm-type electronic blood pressure monitor (Model: YE660D) in measuring systolic blood pressure, diastolic blood pressure and pulse rate in adults aged 12 years and above. (time frame: August 20, 2024 - December 30, 2025). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06565702, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Aug 2024.